In this issue of EuroIntervention, there is an expert consensus from the EAPCI and the ESC Working Group on Thrombosis on antithrombotics and ACS in women. This issue also includes a debate on the current quantitative flow ratio guidelines. In original research, we look at short dual antiplatelet therapy in high bleeding risk patients with diabetes, pacemaker implantation in TAVI for aortic regurgitation, and chimney stenting in redo-TAVI. In a research correspondence, next-day discharge following TAVI via alternative vascular access is discussed. There is also a flashlight on transcaval transcatheter aortic valve implantation via left-sided venous access and a letter to the editor, news from EAPCI; and more...
Original Research
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programme
Oliva A, Angiolillo D, Valgimigli M, Cao D, Sartori S, Bangalore S, Bhatt D, Campo G, Chehab B, Choi J, de la Torre Hernandez J, Feng Y, Ge J, Gitto M, Hermiller J, Krucoff M, Kunadian V, Makkar R, Maksoud A, Neumann F, Picon H, Saito S, Sardella G, Thiele H, Toelg R, Varenne O, Vogel B, Vranckx P, Windecker S, Mehran R
10.4244/EIJ-D-24-00897
Predictors of pacemaker implantation in aortic regurgitation patients treated with a dedicated transcatheter heart valve
Wienemann H, Geyer M, Stukenberg M, Waezsada S, Patel K, Kuhn E, Rogmann M, Pinto D, Conradi L, Bleiziffer S, Baldus S, Baumbach A, Rudolph T, Adam M
10.4244/EIJ-D-24-01117
